| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |